Fundraising Fox
Sensible Biotechnologies
YC S21Oxford, GB · Founded 2021 · Delaware corporation · 24 employees · 19 known investors
Find your way into Sensible Biotechnologies
Sign up to see every warm intro you have to Sensible Biotechnologies
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Sensible Biotechnologies team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Sensible Biotechnologies develops a cell-based mRNA design and manufacturing platform that produces pure, low immunogenicity mRNA therapeutics for drug development. The platform addresses limitations of synthetic mRNA by enabling design-based biology approaches.
Also known as Genbiotics
Founders & leadership· Y Combinator alumni (S21)
Sensible Biotechnologies was founded in 2021 by Miroslav Gasparek and Marian Kupculak.
Board
Investors · 19
How we know: Civilization Ventures Management, Llc's portfolio page · funding news · the VCSheet dataset · open dataset · 5k.vc investor directory · Y Combinator's founder network · Not right? Tell us
How we know: KAYA's portfolio page · the VCSheet dataset · Y Combinator's founder network · Not right? Tell us
How we know: Recode Ventures's portfolio page · Y Combinator's founder network · Not right? Tell us
How we know: Traun Ventures's portfolio page · Y Combinator's founder network · Not right? Tell us
How we know: the Y Combinator directory · funding news · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: ZAKA VC's portfolio page · Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: a partner's Signal profile · funding news · the VCSheet dataset · open dataset · 5k.vc investor directory · Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$15.3M disclosed across 2 rounds · 2023–2026
▶$13.5MraisedSep 2026 · 15 investors · BiotechnologyRule 506(b)
- Miroslav GasparekExecutive Officer, Director
- Marian KupculakExecutive Officer, Director
- Joel SchoppigDirector
- Vishal GulatiDirector
- Offering amount
- $15M
- Amount sold
- $13.5M
- Proceeds to insiders
- $200K
- First sale
- Aug 2026
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$1.8MraisedFeb 2023 · 18 investors · BiotechnologyRule 506(b)
- Marian KupculakExecutive Officer, Director
- Miroslav GasparekExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $1.8M
- Proceeds to insiders
- $100K
- First sale
- Feb 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 9
Companies working in the same space as Sensible Biotechnologies.
Legal entities · 1
corporate structureCompanies House · registry record
View on Companies House ↗- Registered name
- SENSIBLE BIOTECHNOLOGIES LIMITED
- Company number
- 14628427
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 31 Jan 2023
- Registered office
- 3rd Floor 1 Ashley Road, Altrincham, Cheshire, WA14 2DT
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology72190 — Other research and experimental development on natural sciences and engineering
- Accounts
- last made up to 31 Dec 2024 · next due 30 Sept 2026
- Confirmation statement
- last made up to 30 Jan 2026 · next due 13 Feb 2027
Current officers · 2
- Miroslav Gasparek — director, appointed 31 Jan 2023
- Marian Kupculak — director, appointed 31 Jan 2023
Source: Companies House public register · retrieved 24 Jul 2026. Contains public sector information licensed under the Open Government Licence v3.0.
In the news
Frequently asked questions
- What does Sensible Biotechnologies do?
- Sensible Biotechnologies develops a cell-based mRNA design and manufacturing platform that produces pure, low immunogenicity mRNA therapeutics for drug development. The platform addresses limitations of synthetic mRNA by enabling design-based biology approaches.
- Who founded Sensible Biotechnologies?
- Sensible Biotechnologies was founded by Miroslav Gasparek, Marian Kupculak in 2021.
- Who are Sensible Biotechnologies's investors?
- Sensible Biotechnologies's investors include Civilization Ventures Management, Llc, In-Q-Tel, KAYA, Recode Ventures, Traun Ventures, Y Combinator, ZAKA VC, Amino Collective and 11 more.
- How much funding has Sensible Biotechnologies raised?
- Sensible Biotechnologies has disclosed $15.3M raised across 2 rounds.
- Where is Sensible Biotechnologies headquartered?
- Sensible Biotechnologies is headquartered in Oxford, GB.